OPTIMIZATION OF SMALL-SCALE COUPLING OF A5B7-MONOCLONAL ANTIBODY TO CARBOXYPEPTIDASE-G2

被引:38
作者
MELTON, RG [1 ]
BOYLE, JMB [1 ]
ROGERS, GT [1 ]
BURKE, P [1 ]
BAGSHAWE, KD [1 ]
SHERWOOD, RF [1 ]
机构
[1] CHARING CROSS HOSP,DEPT MED ONCOL,CANC RES CAMPAIGN LABS,LONDON W6 8RF,ENGLAND
关键词
CONJUGATE; ANTIBODY-DIRECTED ENZYME-PRODRUG THERAPY; ANTIBODY-ENZYME CONJUGATE; CARBOXYPEPTIDASE-G2; MONOCLONAL ANTIBODY; CARCINOEMBRYONIC ANTIGEN;
D O I
10.1016/0022-1759(93)90257-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Conjugates of F(ab')2 fragment of the monoclonal antibody A5B7 coupled to carboxypeptidase G2 (CPG2) have been produced using the heterobifunctional reagents 2-mercapto-[S-acetyl]acetic acid, N-hydroxysuccinimide ester (SATA) and m-maleimidobenzoyl-N-hydroxysuccinimide ester (SMPB). The effect of various levels of modifying reagent on enzyme activity and antigen binding activity were determined, and it was shown that whilst CPG2 is relatively sensitive to modification, insertion of three maleimide groups per CPG2 resulted in the loss of 30% of enzyme activity; A5B7 F(ab')2 Was insensitive to modification, little or no activity being lost. The coupling efficiency of the reaction was shown to be fairly constant over a wide range of substitution levels. There was thus no advantage to be gained in using high substitution levels, which may result in loss of enzyme activity. The formation of undesired high molecular weight aggregates could be controlled by adjustment of the protein concentration during the final coupling step.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 17 条
[1]   A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES [J].
BAGSHAWE, KD ;
SPRINGER, CJ ;
SEARLE, F ;
ANTONIW, P ;
SHARMA, SK ;
MELTON, RG ;
SHERWOOD, RF .
BRITISH JOURNAL OF CANCER, 1988, 58 (06) :700-703
[2]   THE 1ST BAGSHAWE LECTURE - TOWARDS GENERATING CYTO-TOXIC AGENTS AT CANCER SITES [J].
BAGSHAWE, KD .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :275-281
[3]  
BAGSHAWE KD, 1991, DIS MARKERS, V9, P233
[4]  
BERNHARD MI, 1983, CANCER RES, V43, P4420
[5]   MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF A FUSION PROTEIN SUITED FOR TUMOR SPECIFIC PRODRUG ACTIVATION [J].
BOSSLET, K ;
CZECH, J ;
LORENZ, P ;
SEDLACEK, HH ;
SCHUERMANN, M ;
SEEMANN, G .
BRITISH JOURNAL OF CANCER, 1992, 65 (02) :234-238
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   A NEW REAGENT WHICH MAY BE USED TO INTRODUCE SULFHYDRYL-GROUPS INTO PROTEINS, AND ITS USE IN THE PREPARATION OF CONJUGATES FOR IMMUNOASSAY [J].
DUNCAN, RJS ;
WESTON, PD ;
WRIGGLESWORTH, R .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :68-73
[8]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[9]  
MARTIN FJ, 1982, J BIOL CHEM, V257, P286
[10]   COMPARISON OF METHODS FOR THE GENERATION OF IMMUNOREACTIVE FRAGMENTS OF A MONOCLONAL-ANTIBODY (B72.3) REACTIVE WITH HUMAN CARCINOMAS [J].
MILENIC, DE ;
ESTEBAN, JM ;
COLCHER, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 120 (01) :71-83